Cogent Biosciences's total assets for Q1 2026 were $903.01M, a decrease of -3.69% from the previous quarter. COGT total liabilities were $295.31M for the fiscal quarter, a -1.97% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.